Gerald D. Schellenberg

4.8k total citations
26 papers, 1.7k citations indexed

About

Gerald D. Schellenberg is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Gerald D. Schellenberg has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 10 papers in Molecular Biology and 7 papers in Psychiatry and Mental health. Recurrent topics in Gerald D. Schellenberg's work include Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (7 papers) and Prion Diseases and Protein Misfolding (3 papers). Gerald D. Schellenberg is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (7 papers) and Prion Diseases and Protein Misfolding (3 papers). Gerald D. Schellenberg collaborates with scholars based in United States, Australia and Iran. Gerald D. Schellenberg's co-authors include Eric B. Larson, James D. Bowen, Wayne C. McCormick, Amy Borenstein Graves, Susan M. McCurry, James B. Leverenz, Suzanne Craft, Paul K. Crane, Sebastien Haneuse and Joshua A. Sonnen and has published in prestigious journals such as Neurology, Annals of Neurology and The American Journal of Human Genetics.

In The Last Decade

Gerald D. Schellenberg

25 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald D. Schellenberg United States 17 673 524 376 371 282 26 1.7k
Daniela Carnevale Italy 31 473 0.7× 237 0.5× 737 2.0× 722 1.9× 191 0.7× 67 2.4k
Xiaoniu Liang China 22 501 0.7× 567 1.1× 219 0.6× 248 0.7× 297 1.1× 85 1.6k
Elizabeth M. Rhea United States 22 714 1.1× 114 0.2× 573 1.5× 579 1.6× 415 1.5× 49 2.2k
Sigrid Botne Sando Norway 22 649 1.0× 384 0.7× 228 0.6× 302 0.8× 242 0.9× 41 1.3k
J. Lincoln United Kingdom 34 1.1k 1.7× 267 0.5× 206 0.5× 733 2.0× 182 0.6× 71 3.2k
Monika Balzer‐Geldsetzer Germany 24 219 0.3× 235 0.4× 150 0.4× 283 0.8× 507 1.8× 56 1.7k
Angela J. Hanson United States 14 790 1.2× 120 0.2× 280 0.7× 316 0.9× 69 0.2× 36 1.5k
Amy C. Arnold United States 28 394 0.6× 146 0.3× 148 0.4× 290 0.8× 403 1.4× 97 2.3k
J.F. Martí-Massó Spain 30 552 0.8× 311 0.6× 399 1.1× 506 1.4× 1.8k 6.4× 146 2.8k
Karen Lund Canada 12 2.4k 3.6× 206 0.4× 168 0.4× 555 1.5× 1.0k 3.5× 21 3.8k

Countries citing papers authored by Gerald D. Schellenberg

Since Specialization
Citations

This map shows the geographic impact of Gerald D. Schellenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald D. Schellenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald D. Schellenberg more than expected).

Fields of papers citing papers by Gerald D. Schellenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald D. Schellenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald D. Schellenberg. The network helps show where Gerald D. Schellenberg may publish in the future.

Co-authorship network of co-authors of Gerald D. Schellenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald D. Schellenberg. A scholar is included among the top collaborators of Gerald D. Schellenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald D. Schellenberg. Gerald D. Schellenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hui, Timothy S. Chang, Beth A. Dombroski, et al.. (2024). Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and MAPT Sub‐haplotypes. Alzheimer s & Dementia. 20(S1). e086923–e086923.
2.
Martin, Eden R., Gerald D. Schellenberg, Margaret A. Pericak‐Vance, et al.. (2023). GWAS identifies genetic factors associated with severity of cerebral amyloid angiopathy pathology. Alzheimer s & Dementia. 19(S12). 1 indexed citations
3.
Bekris, Lynn M., Steven P. Millard, David J. Lockhart, et al.. (2011). Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiology of Aging. 32(3). 556.e13–556.e23. 45 indexed citations
4.
Watson, G. Stennis, Laura D. Baker, Kristoffer Rhoads, et al.. (2010). Statin Users Without an APOE-ε4 Allele have Increased Insulin Resistance. Journal of Alzheimer s Disease. 19(4). 1149–1153. 7 indexed citations
5.
Borenstein, Amy R., James A. Mortimer, Elizabeth Schofield, et al.. (2007). Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology. 68(21). 1764–1771. 65 indexed citations
6.
Galasko, Douglas, David P. Salmon, Anthony Gamst, et al.. (2007). Prevalence of dementia in Chamorros on Guam. Neurology. 68(21). 1772–1781. 47 indexed citations
7.
Sonnen, Joshua A., Eric B. Larson, Paul K. Crane, et al.. (2007). Pathological correlates of dementia in a longitudinal, population‐based sample of aging. Annals of Neurology. 62(4). 406–413. 336 indexed citations
8.
Faraone, Stephen V., Andrew D. Skol, Debby W. Tsuang, et al.. (2005). Genome scan of schizophrenia families in a large Veterans Affairs Cooperative Study sample: Evidence for linkage to 18p11.32 and for racial heterogeneity on chromosomes 6 and 14. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 139B(1). 91–100. 16 indexed citations
9.
Shofer, Jane B., Walter A. Kukull, Elaine R. Peskind, et al.. (2005). Serum cholesterol and risk of Alzheimer disease. Neurology. 65(7). 1045–1050. 129 indexed citations
10.
Hall, Deborah A., Maureen A. Leehey, Christopher M. Filley, et al.. (2005). PRNP H187R mutation associated with neuropsychiatric disorders in childhood and dementia. Neurology. 64(7). 1304–1306. 19 indexed citations
11.
Skol, Andrew D., Keith A. Young, Debby W. Tsuang, et al.. (2002). Modest evidence for linkage and possible confirmation of association between NOTCH4 and schizophrenia in a large veterans affairs cooperative study sample. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 118B(1). 8–15. 27 indexed citations
12.
Zareparsi, Sepideh, et al.. (2002). HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease. Neurology. 58(6). 973–975. 23 indexed citations
13.
Graves, Amy Borenstein, James D. Bowen, Lakshminarayan Rajaram, et al.. (1999). Impaired olfaction as a marker for cognitive decline. Neurology. 53(7). 1480–1480. 237 indexed citations
14.
Hubble, Jean, Janice Kurth, S. L. Glatt, et al.. (1998). Gene-Toxin Interaction as a Putative Risk Factor for Parkinson’s Disease with Dementia. Neuroepidemiology. 17(2). 96–104. 28 indexed citations
15.
Carmelli, Dorit, Gary E. Swan, T. Reed, et al.. (1998). Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology. 50(6). 1580–1585. 123 indexed citations
16.
Scheuner, Donalyn, Christopher B. Eckman, Martin Citron, et al.. (1996). 149 The Presenilin 1 and 2 mutations linked to familial Alzheimer's Disease increase the extracellular concentration of amyloid 0 protein (Aβ) ending at Aβ42(43). Neurobiology of Aging. 17(4). S38–S38. 2 indexed citations
17.
Schellenberg, Gerald D., Ellen M. Wijsman, & Thomas D. Bird. (1994). Genetic heterogeneity and Alzheimer`s disease. The American Journal of Human Genetics. 55. 2 indexed citations
18.
Yu, Chang, et al.. (1994). Dinucleotide repeat polymorphism at the FGFR1 gene. Human Molecular Genetics. 3(1). 212–212. 7 indexed citations
19.
Hsiao, Karen, et al.. (1991). A prion protein variant in a family with the telencephalic form of Gerstmann‐Straussler‐Scheinker syndrome. Neurology. 41(5). 681–684. 120 indexed citations
20.
Schellenberg, Gerald D., et al.. (1989). The genetics of Alzheimer's disease. Biomedicine & Pharmacotherapy. 43(7). 463–468. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Carnevale Breakdown of academic impact, for papers by Xiaoniu Liang Breakdown of academic impact, for papers by Elizabeth M. Rhea Breakdown of academic impact, for papers by Sigrid Botne Sando Breakdown of academic impact, for papers by J. Lincoln Breakdown of academic impact, for papers by Monika Balzer‐Geldsetzer Breakdown of academic impact, for papers by Angela J. Hanson Breakdown of academic impact, for papers by Amy C. Arnold Breakdown of academic impact, for papers by J.F. Martí-Massó Breakdown of academic impact, for papers by Karen Lund
Rankless by CCL
2026